{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:22:30Z","timestamp":1787952150437,"version":"build-2784847793"},"reference-count":160,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Blood Reviews"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.blre.2026.101394","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T06:13:21Z","timestamp":1777011201000},"page":"101394","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Supportive strategies in thrombocytopenia: Platelet transfusion and beyond"],"prefix":"10.1016","volume":"77","author":[{"given":"Tom\u00e1s Jos\u00e9","family":"Gonz\u00e1lez-L\u00f3pez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Kuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drew","family":"Provan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.blre.2026.101394_bb0005","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1001\/jama.2025.7529","article-title":"Platelet transfusion: 2025 AABB and ICTMG international clinical practice guidelines","volume":"334","author":"Metcalf","year":"2025","journal-title":"JAMA"},{"issue":"8","key":"10.1016\/j.blre.2026.101394_bb0010","first-page":"735","article-title":"How well do platelets prevent bleeding?","volume":"115","author":"Triulzi","year":"2020","journal-title":"Vox Sang"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0015","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/s13613-025-01447-x","article-title":"Thrombocytopenia in the intensive care unit: diagnosis and management","volume":"15","author":"P\u00e8ne","year":"2025","journal-title":"Ann Intensive Care"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0020","first-page":"93","article-title":"Management of thrombocytopenia","volume":"3","author":"Izak","year":"2014","journal-title":"J Hematol"},{"key":"10.1016\/j.blre.2026.101394_bb0025","first-page":"29","article-title":"Platelet transfusion for patients with platelet dysfunction or thrombocytopenia: a narrative review","volume":"5","author":"Lee","year":"2020","journal-title":"Ann Blood"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0030","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/bjh.14423","article-title":"Guidelines for the use of platelet transfusions","volume":"176","author":"Estcourt","year":"2017","journal-title":"Br J Haematol"},{"issue":"7","key":"10.1016\/j.blre.2026.101394_bb0035","first-page":"633","article-title":"Thrombocytopenia due to diminished platelet production","volume":"360","author":"George","year":"2009","journal-title":"N Engl J Med"},{"issue":"13","key":"10.1016\/j.blre.2026.101394_bb0040","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1056\/NEJMra010501","article-title":"Immune thrombocytopenic purpura","volume":"346","author":"Cines","year":"2002","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.blre.2026.101394_bb0045","doi-asserted-by":"crossref","first-page":"886","DOI":"10.7326\/0003-4819-129-11_Part_1-199812010-00009","article-title":"Drug-induced thrombocytopenia: a systematic review of published case reports","volume":"129","author":"George","year":"1998","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0050","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMra066469","article-title":"Drug-induced immune thrombocytopenia","volume":"357","author":"Aster","year":"2007","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.blre.2026.101394_bb0055","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1056\/NEJMcp1810479","article-title":"Immune thrombocytopenia","volume":"381","author":"Cooper","year":"2019","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.blre.2026.101394_bb0060","article-title":"SARS-CoV-2\u2013associated immune thrombocytopenia","volume":"383","author":"Cines","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.blre.2026.101394_bb0065","doi-asserted-by":"crossref","first-page":"649","DOI":"10.3389\/fimmu.2014.00649","article-title":"Platelets and infection\u2014an emerging role of platelets in viral infection","volume":"5","author":"Assinger","year":"2014","journal-title":"Front Immunol"},{"issue":"23","key":"10.1016\/j.blre.2026.101394_bb0070","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1182\/bloodadvances.2019000966","article-title":"American society of hematology 2019 guidelines for immune thrombocytopenia","volume":"3","author":"Neunert","year":"2019","journal-title":"Blood Adv"},{"issue":"22","key":"10.1016\/j.blre.2026.101394_bb0075","doi-asserted-by":"crossref","first-page":"3780","DOI":"10.1182\/bloodadvances.2019000812","article-title":"Updated international consensus report on the investigation and management of primary immune thrombocytopenia","volume":"3","author":"Provan","year":"2019","journal-title":"Blood Adv"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0080","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1200\/JCO.2017.76.1734","article-title":"Platelet transfusion for patients with cancer: American society of clinical oncology clinical practice guideline update","volume":"36","author":"Schiffer","year":"2018","journal-title":"J Clin Oncol"},{"issue":"7","key":"10.1016\/j.blre.2026.101394_bb0085","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1056\/NEJMoa0904084","article-title":"Dose of prophylactic platelet transfusions and prevention of hemorrhage","volume":"362","author":"Slichter","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0090","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/jth.13571","article-title":"Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura","volume":"15","author":"Scully","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"22","key":"10.1016\/j.blre.2026.101394_bb0095","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1182\/bloodadvances.2018024489","article-title":"American society of hematology 2018 guidelines for management of heparin-induced thrombocytopenia","volume":"2","author":"Cuker","year":"2018","journal-title":"Blood Adv"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0100","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1056\/NEJMra1011170","article-title":"The coagulopathy of chronic liver disease","volume":"365","author":"Tripodi","year":"2011","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0105","first-page":"1055","article-title":"Epstein\u2013Barr virus\u2013associated thrombocytopenia in children","volume":"56","author":"Tsai","year":"2011","journal-title":"Pediatr Blood Cancer"},{"issue":"7","key":"10.1016\/j.blre.2026.101394_bb0110","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1056\/NEJM200008173430707","article-title":"Epstein\u2013Barr virus infection","volume":"343","author":"Cohen","year":"2000","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0115","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1128\/CMR.00035-09","article-title":"Dengue virus pathogenesis: an integrated view","volume":"22","author":"Martina","year":"2009","journal-title":"Clin Microbiol Rev"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0120","first-page":"1","article-title":"Immune-mediated platelet destruction in dengue hemorrhagic fever","volume":"90","author":"Srikiatkhachorn","year":"2014","journal-title":"Am J Trop Med Hyg"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0125","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/s00134-019-05906-5","article-title":"Diagnosis of severe infections in immunocompromised patients","volume":"46","author":"Azoulay","year":"2020","journal-title":"Intensive Care Med"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0130","doi-asserted-by":"crossref","first-page":"e56","DOI":"10.1093\/cid\/cir073","article-title":"Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America","volume":"52","author":"Freifeld","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"14","key":"10.1016\/j.blre.2026.101394_bb0135","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1200\/JCO.2017.77.6211","article-title":"Outpatient management of fever and neutropenia in adults treated for malignancy: ASCO and IDSA clinical practice guideline update","volume":"36","author":"Taplitz","year":"2018","journal-title":"J Clin Oncol"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0140","first-page":"356","article-title":"Short- and long-term risks of bleeding in immune thrombocytopenia","volume":"31","author":"Rodeghiero","year":"2017","journal-title":"Blood Rev"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0145","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1182\/asheducation-2007.1.172","article-title":"Platelet transfusion therapy","volume":"2007","author":"Slichter","year":"2007","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"19","key":"10.1016\/j.blre.2026.101394_bb0150","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1056\/NEJMoa1212772","article-title":"A no-prophylaxis platelet-transfusion strategy for hematologic cancers","volume":"368","author":"Stanworth","year":"2013","journal-title":"N Engl J Med"},{"issue":"26","key":"10.1016\/j.blre.2026.101394_bb0155","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1056\/NEJM199712253372601","article-title":"Leukocyte reduction and ultraviolet B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions","volume":"337","author":"Trial to Reduce Alloimmunization to Platelets Study Group","year":"1997","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0160","first-page":"90","article-title":"Platelet transfusion\u2014ABO compatibility","volume":"29","author":"Cid","year":"2015","journal-title":"Transfus Med Rev"},{"key":"10.1016\/j.blre.2026.101394_bb0165","series-title":"Standards for blood banks and transfusion services","year":"2018"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0170","first-page":"348","article-title":"Immune platelet transfusion refractoriness","volume":"162","author":"Pavenski","year":"2013","journal-title":"Br J Haematol"},{"issue":"5","key":"10.1016\/j.blre.2026.101394_bb0175","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jama.2015.12","article-title":"Transfusion of plasma, platelets, and red blood cells in a 1:1:1 vs a 1:1:2 ratio and mortality in patients with severe trauma: the PROPPR randomized clinical trial","volume":"313","author":"Holcomb","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.blre.2026.101394_bb0180","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1186\/s13054-019-2347-3","article-title":"The European guideline on management of major bleeding and coagulopathy following trauma: fifth edition","volume":"23","author":"Spahn","year":"2019","journal-title":"Crit Care"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0185","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/EJA.0000000000000630","article-title":"Management of severe perioperative bleeding: guidelines from the European Society of Anaesthesiology","volume":"34","author":"Kozek-Langenecker","year":"2017","journal-title":"Eur J Anaesthesiol"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0190","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1365-2141.2009.07899.x","article-title":"The risk of spinal haematoma following neuraxial anaesthesia or lumbar puncture in thrombocytopenic individuals","volume":"148","author":"Van Veen","year":"2010","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0195","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1046\/j.1365-2141.2003.04468.x","article-title":"Guidelines for the use of platelet transfusions","volume":"122","author":"British Committee for Standards in Haematology","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0200","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1046\/j.1365-2141.2003.04329.x","article-title":"Bone marrow biopsy morbidity and mortality","volume":"121","author":"Bain","year":"2003","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0205","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1093\/ajcp\/94.6.747","article-title":"Lack of increased bleeding after bone marrow biopsy in thrombocytopenic patients","volume":"94","author":"McVay","year":"1990","journal-title":"Am J Clin Pathol"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2026.101394_bb0210","first-page":"i1","article-title":"British thoracic society guidelines on diagnostic flexible bronchoscopy","volume":"68","author":"British Thoracic Society Bronchoscopy Guideline Committee","year":"2013","journal-title":"Thorax"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2026.101394_bb0215","doi-asserted-by":"crossref","first-page":"i1","DOI":"10.1136\/thoraxjnl-2013-203618","article-title":"British thoracic society guideline for diagnostic flexible bronchoscopy in adults","volume":"68","author":"Du Rand","year":"2013","journal-title":"Thorax"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0220","first-page":"552","article-title":"Central venous catheter placement in coagulopathic patients: a systematic review","volume":"43","author":"van de Weerdt","year":"2017","journal-title":"Intensive Care Med"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0225","first-page":"784","article-title":"Central venous catheter placement in children with severe thrombocytopenia","volume":"105","author":"Haas","year":"2010","journal-title":"Br J Anaesth"},{"issue":"9850","key":"10.1016\/j.blre.2026.101394_bb0230","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(12)60689-8","article-title":"Therapeutic platelet transfusion versus routine prophylactic transfusion in patients with haematological malignancies: an open-label, multicentre, randomised study","volume":"380","author":"Wandt","year":"2012","journal-title":"Lancet"},{"issue":"11","key":"10.1016\/j.blre.2026.101394_bb0235","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1111\/jth.13126","article-title":"A critical appraisal of point-of-care coagulation testing in critically ill patients","volume":"13","author":"Levi","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"26","key":"10.1016\/j.blre.2026.101394_bb0240","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1056\/NEJM199712253372602","article-title":"The threshold for prophylactic platelet transfusions in thrombocytopenic patients and its effect on major bleeding","volume":"337","author":"Rebulla","year":"1997","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.blre.2026.101394_bb0245","first-page":"998","article-title":"Threshold for prophylactic platelet transfusion during induction and consolidation chemotherapy in acute myeloid leukemia","volume":"83","author":"Navarro","year":"1998","journal-title":"Haematologica"},{"issue":"5","key":"10.1016\/j.blre.2026.101394_bb0250","first-page":"623","article-title":"Indications for platelet transfusion in patients with hematologic malignancies","volume":"164","author":"Squires","year":"2014","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.blre.2026.101394_bb0255","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1182\/blood-2008-04-150250","article-title":"Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet","volume":"113","author":"Sanz","year":"2009","journal-title":"Blood"},{"issue":"25","key":"10.1016\/j.blre.2026.101394_bb0260","doi-asserted-by":"crossref","first-page":"5126","DOI":"10.1182\/blood-2009-07-216457","article-title":"How I treat acute promyelocytic leukemia","volume":"114","author":"Tallman","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0265","first-page":"321","article-title":"Advances in the management of acute promyelocytic leukemia","volume":"2014","author":"Sanz","year":"2014","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0270","first-page":"271","article-title":"Improved outcomes with ATRA and arsenic trioxide in acute promyelocytic leukemia: updated recommendations","volume":"129","author":"Platzbecker","year":"2017","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.blre.2026.101394_bb0275","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.3109\/10428194.2011.596963","article-title":"Prevention and management of asparaginase-related toxicity in adults treated for acute lymphoblastic leukemia","volume":"52","author":"Stock","year":"2011","journal-title":"Leuk Lymphoma"},{"issue":"11","key":"10.1016\/j.blre.2026.101394_bb0280","first-page":"2163","article-title":"The frequency and management of asparaginase-related coagulation abnormalities in adults with acute lymphoblastic leukemia","volume":"9","author":"Grace","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0285","first-page":"427","article-title":"Trend in thrombotic complications in children with acute lymphoblastic leukemia treated with L-asparaginase","volume":"102","author":"Mitchell","year":"2003","journal-title":"Blood"},{"issue":"9617","key":"10.1016\/j.blre.2026.101394_bb0290","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1016\/S0140-6736(08)60457-2","article-title":"Acute lymphoblastic leukaemia","volume":"371","author":"Pui","year":"2008","journal-title":"Lancet"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0295","first-page":"245","article-title":"Platelet transfusions for patients with solid tumors receiving chemotherapy","volume":"26","author":"Estcourt","year":"2012","journal-title":"Blood Rev"},{"issue":"5","key":"10.1016\/j.blre.2026.101394_bb0300","first-page":"1147","article-title":"Incidence, cost, and outcomes of bleeding complications in patients with cancer","volume":"92","author":"Elting","year":"2001","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0305","first-page":"597","article-title":"Managing thrombocytopenia associated with cancer chemotherapy","volume":"20","author":"Kuter","year":"2015","journal-title":"Oncologist"},{"issue":"17","key":"10.1016\/j.blre.2026.101394_bb0310","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young","year":"2018","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0315","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick","year":"2016","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0320","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1056\/NEJMoa1807320","article-title":"Randomized trial of platelet-transfusion thresholds in neonates","volume":"380","author":"Curley","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.blre.2026.101394_bb0325","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1056\/NEJMcp053024","article-title":"Thrombotic thrombocytopenic purpura","volume":"354","author":"George","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0330","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","article-title":"Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura","volume":"158","author":"Scully","year":"2012","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0335","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1056\/NEJMcp1411910","article-title":"Heparin-induced thrombocytopenia","volume":"373","author":"Greinacher","year":"2015","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.blre.2026.101394_bb0340","first-page":"1931","article-title":"Platelet transfusions in thrombotic thrombocytopenic purpura: a systematic review","volume":"55","author":"Goel","year":"2015","journal-title":"Transfusion"},{"issue":"9","key":"10.1016\/j.blre.2026.101394_bb0345","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1016\/j.cgh.2013.02.026","article-title":"Coagulation in liver disease: a guide for the clinician","volume":"11","author":"Northup","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0350","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1111\/j.1365-2141.2009.07600.x","article-title":"Guidelines for the diagnosis and management of disseminated intravascular coagulation","volume":"145","author":"Levi","year":"2009","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0355","first-page":"241","article-title":"The withdrawal of guidelines on DIC: a critical appraisal","volume":"28","author":"Thachil","year":"2014","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0360","first-page":"e190","article-title":"Glanzmann thrombasthenia: a review of clinical presentation, diagnosis, and management","volume":"18","author":"Nurden","year":"2012","journal-title":"Haemophilia"},{"issue":"5","key":"10.1016\/j.blre.2026.101394_bb0365","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1111\/j.1365-2141.2006.06343.x","article-title":"A review of inherited platelet disorders with guidelines for their management on behalf of the UK Haemophilia Centre Doctors\u2019 Organisation","volume":"135","author":"Bolton-Maggs","year":"2006","journal-title":"Br J Haematol"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0370","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jth.12792","article-title":"Diagnosis and management of inherited platelet function disorders: guidance from the SSC of the ISTH","volume":"13","author":"Gresele","year":"2015","journal-title":"J Thromb Haemost"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0375","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3324\/haematol.2010.039883","article-title":"Bernard\u2013Soulier syndrome","volume":"96","author":"Berndt","year":"2011","journal-title":"Haematologica"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0380","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.jaci.2006.02.005","article-title":"The Wiskott\u2013Aldrich syndrome","volume":"117","author":"Ochs","year":"2006","journal-title":"J Allergy Clin Immunol"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0385","first-page":"298","article-title":"Platelet abnormalities in uremia","volume":"11","author":"Remuzzi","year":"1985","journal-title":"Semin Thromb Hemost"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0390","first-page":"316","article-title":"Increased mean platelet volume in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"84","author":"Lippi","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"issue":"13","key":"10.1016\/j.blre.2026.101394_bb0395","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1182\/blood-2013-03-460154","article-title":"Myeloproliferative neoplasms and thrombosis","volume":"122","author":"Barbui","year":"2013","journal-title":"Blood"},{"issue":"2 Suppl","key":"10.1016\/j.blre.2026.101394_bb0400","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1097\/CCM.0b013e3181c98d21","article-title":"Inflammation and coagulation","volume":"38","author":"Levi","year":"2010","journal-title":"Crit Care Med"},{"issue":"5 Suppl","key":"10.1016\/j.blre.2026.101394_bb0405","doi-asserted-by":"crossref","first-page":"S313","DOI":"10.1097\/00003246-200205001-00022","article-title":"Platelet function in sepsis","volume":"30","author":"Vincent","year":"2002","journal-title":"Crit Care Med"},{"key":"10.1016\/j.blre.2026.101394_bb0410","series-title":"StatPearls [Internet]","article-title":"Antiplatelet medications","author":"Iqbal","year":"2022"},{"issue":"8","key":"10.1016\/j.blre.2026.101394_bb0415","first-page":"1005","article-title":"Clinical pharmacology of antiplatelet drugs","volume":"61","author":"Gelbenegger","year":"2022","journal-title":"Clin Pharmacokinet"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0420","first-page":"281","article-title":"Antiplatelet agents: mechanisms of action and clinical use","volume":"20","author":"Varon","year":"2009","journal-title":"Crit Rev Cardiovasc Med"},{"key":"10.1016\/j.blre.2026.101394_bb0425","series-title":"StatPearls [Internet]","article-title":"Glycoprotein IIb\/IIIa inhibitors","author":"Tummala","year":"2023"},{"issue":"10038","key":"10.1016\/j.blre.2026.101394_bb0430","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1016\/S0140-6736(16)30392-0","article-title":"PATCH Investigators. Platelet transfusion versus standard care after acute stroke due to spontaneous cerebral haemorrhage associated with antiplatelet therapy (PATCH): a randomised, open-label, phase 3 trial","volume":"387","author":"Baharoglu","year":"2016","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0435","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12028-011-9619-3","article-title":"Early platelet transfusion improves platelet activity and may improve outcomes after intracerebral hemorrhage","volume":"16","author":"Naidech","year":"2012","journal-title":"Neurocrit Care"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0440","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12028-015-0222-x","article-title":"Guideline for reversal of antithrombotics in intracranial hemorrhage: a statement for healthcare professionals from the neurocritical care society and society of critical care medicine","volume":"24","author":"Frontera","year":"2016","journal-title":"Neurocrit Care"},{"issue":"5","key":"10.1016\/j.blre.2026.101394_bb0445","first-page":"764","article-title":"No benefit from platelet transfusion for gastrointestinal bleeding in patients taking antiplatelet agents","volume":"112","author":"Zakko","year":"2017","journal-title":"Am J Gastroenterol"},{"issue":"9800","key":"10.1016\/j.blre.2026.101394_bb0450","first-page":"126","article-title":"Red blood cell transfusion practice in patients with acute upper gastrointestinal bleeding: a prospective cohort study","volume":"378","author":"Jairath","year":"2011","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0455","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/j.athoracsur.2010.11.078","article-title":"2011 update to the society of thoracic surgeons and the society of cardiovascular anesthesiologists blood conservation clinical practice guidelines","volume":"91","author":"Ferraris","year":"2011","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0460","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s12028-011-9619-3","article-title":"Early platelet transfusion improves platelet activity but not outcomes after intracerebral hemorrhage","volume":"16","author":"Naidech","year":"2012","journal-title":"Neurocrit Care"},{"issue":"26","key":"10.1016\/j.blre.2026.101394_bb0465","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1182\/blood-2014-06-583294","article-title":"Ibrutinib treatment affects collagen and von Willebrand factor\u2013dependent platelet functions","volume":"124","author":"Levade","year":"2014","journal-title":"Blood"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0470","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/leu.2014.247","article-title":"Ibrutinib inhibits collagen-mediated but not ADP-mediated platelet aggregation","volume":"29","author":"Kamel","year":"2015","journal-title":"Leukemia"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0475","first-page":"307","article-title":"Damage control resuscitation: directly addressing the early coagulopathy of trauma","volume":"62","author":"Holcomb","year":"2007","journal-title":"J Trauma"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0480","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.bpa.2009.11.001","article-title":"Platelet transfusions: the science behind safety, risks and appropriate applications","volume":"24","author":"Spiess","year":"2010","journal-title":"Best Pract Res Clin Anaesthesiol"},{"issue":"5 Suppl","key":"10.1016\/j.blre.2026.101394_bb0485","doi-asserted-by":"crossref","first-page":"S1821","DOI":"10.1016\/S0003-4975(01)03211-8","article-title":"Mechanisms and attenuation of hemostatic activation during extracorporeal circulation","volume":"72","author":"Despotis","year":"2001","journal-title":"Ann Thorac Surg"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2026.101394_bb0490","first-page":"S10","article-title":"Clinical consequences of red cell and platelet transfusion","volume":"53","author":"Tinmouth","year":"2013","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0495","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.blre.2007.07.003","article-title":"Transfusion-related immunomodulation (TRIM): an update","volume":"21","author":"Vamvakas","year":"2007","journal-title":"Blood Rev"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0500","first-page":"356","article-title":"Pathogen reduction for platelets\u2014current status and future prospects","volume":"122","author":"Williamson","year":"2003","journal-title":"Br J Haematol"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0505","first-page":"509","article-title":"Platelet transfusions: the effect of storage and dose on post-transfusion platelet increments","volume":"64","author":"Murphy","year":"1986","journal-title":"Br J Haematol"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0510","first-page":"62","article-title":"Bleeding risks and platelet transfusion thresholds in pediatric patients","volume":"52","author":"Josephson","year":"2012","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.blre.2026.101394_bb0515","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/bjh.14233","article-title":"Guidelines on transfusion for fetuses, neonates and older children","volume":"175","author":"New","year":"2016","journal-title":"Br J Haematol"},{"issue":"11","key":"10.1016\/j.blre.2026.101394_bb0520","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.1046\/j.1537-2995.2002.00208.x","article-title":"Guidelines for assessing appropriateness of pediatric transfusion","volume":"42","author":"Roseff","year":"2002","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2026.101394_bb0525","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1182\/blood-2008-09-178236","article-title":"A randomized controlled trial comparing standard- and low-dose strategies for transfusion of platelets (SToP) to patients with thrombocytopenia","volume":"113","author":"Heddie","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0530","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1537-2995.2008.02010.x","article-title":"Transfusion-associated circulatory overload: the plot thickens","volume":"44","author":"Popovsky","year":"2004","journal-title":"Transfusion"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0535","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/ALN.0000000000001506","article-title":"Risk factors and clinical outcomes associated with perioperative transfusion-associated circulatory overload","volume":"127","author":"Clifford","year":"2017","journal-title":"Anesthesiology"},{"issue":"7","key":"10.1016\/j.blre.2026.101394_bb0540","first-page":"1766","article-title":"Use of leukocyte-depleted blood components and HLA-matched platelets to prevent HLA alloimmunization in patients with acute leukemia","volume":"78","author":"Murphy","year":"1991","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0545","first-page":"477","article-title":"The role of leukocyte reduction in transfusion medicine","volume":"113","author":"Blajchman","year":"2001","journal-title":"Br J Haematol"},{"issue":"9","key":"10.1016\/j.blre.2026.101394_bb0550","doi-asserted-by":"crossref","first-page":"3598","DOI":"10.1182\/blood.V86.9.3598.bloodjournal8693598","article-title":"A comparison of filtered leukocyte-reduced and cytomegalovirus-seronegative blood products for the prevention of transfusion-associated cytomegalovirus infection after marrow transplant","volume":"86","author":"Bowden","year":"1995","journal-title":"Blood"},{"key":"10.1016\/j.blre.2026.101394_bb0555","series-title":"Practical Transfusion Medicine","author":"Murphy","year":"2013"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0560","first-page":"1113","article-title":"ABO matching of platelet transfusions: a strategy to improve transfusion safety","volume":"49","author":"Blumberg","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/j.blre.2026.101394_bb0565","series-title":"Technical manual","year":"2020"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0570","first-page":"1230","article-title":"Cost-effectiveness of Rh immune globulin after transfusion of RhD-positive platelets to RhD-negative females of childbearing potential","volume":"53","author":"Kacker","year":"2013","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0575","first-page":"938","article-title":"Policies and procedures related to testing for anti-D in blood donors and recipients","volume":"55","author":"Sandler","year":"2015","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.blre.2026.101394_bb0580","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1111\/trf.18465","article-title":"A survey on the use of Rh immune globulin during a nationwide shortage","volume":"65","author":"O\u2019Brien","year":"2025","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0585","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1537-2995.2010.02953.x","article-title":"Platelet transfusions from D+ donors to D- patients: a 10-year follow-up study of 1014 patients","volume":"51","author":"Cid","year":"2011","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0590","first-page":"574","article-title":"Platelet transfusion refractoriness: how do I diagnose and manage?","volume":"2018","author":"Trial","year":"2018","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"8","key":"10.1016\/j.blre.2026.101394_bb0595","first-page":"914","article-title":"Effect of short-term vs long-term blood storage on mortality after transfusion","volume":"299","author":"Heddle","year":"2008","journal-title":"JAMA"},{"issue":"7","key":"10.1016\/j.blre.2026.101394_bb0600","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1111\/j.1537-2995.2008.01731.x","article-title":"Comparative effectiveness of apheresis and whole-blood\u2013derived platelet transfusions: a systematic review","volume":"48","author":"Heddle","year":"2008","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0605","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1128\/CMR.18.1.195-204.2005","article-title":"Bacterial contamination of blood components","volume":"18","author":"Brecher","year":"2005","journal-title":"Clin Microbiol Rev"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0610","first-page":"339","article-title":"Detection of bacterial contamination in platelets: a review of current methods and challenges","volume":"25","author":"Jacobs","year":"2011","journal-title":"Transfus Med Rev"},{"issue":"7","key":"10.1016\/j.blre.2026.101394_bb0615","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1111\/j.1537-2995.2007.01248.x","article-title":"Bacterial screening of apheresis platelets and the residual risk of septic transfusion reactions","volume":"47","author":"Eder","year":"2007","journal-title":"Transfusion"},{"issue":"12","key":"10.1016\/j.blre.2026.101394_bb0620","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1046\/j.1537-2995.2001.41121493.x","article-title":"Transfusion-transmitted bacterial infection in the United States, 1998\u20132000: risk and outcomes","volume":"41","author":"Kuehnert","year":"2001","journal-title":"Transfusion"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0625","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/01.CCM.0000159849.94750.51","article-title":"Transfusion-related acute lung injury: definition and review","volume":"33","author":"Toy","year":"2005","journal-title":"Crit Care Med"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0630","first-page":"1165","article-title":"Anaphylactic transfusion reactions","volume":"51","author":"Savage","year":"2011","journal-title":"Transfusion"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0635","first-page":"829","article-title":"A randomized controlled trial comparing plasma removal with standard platelet transfusions to prevent allergic transfusion reactions","volume":"42","author":"Heddle","year":"2002","journal-title":"Transfusion"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0640","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/j.1537-2995.2008.01941.x","article-title":"The accuracy of natriuretic peptides (BNP and NT-proBNP) in the differentiation between transfusion-related acute lung injury and transfusion-associated circulatory overload","volume":"49","author":"Li","year":"2009","journal-title":"Transfusion"},{"issue":"8","key":"10.1016\/j.blre.2026.101394_bb0645","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1111\/j.1537-2995.2010.02652.x","article-title":"Effective reduction of transfusion-related acute lung injury risk with plasma mitigation strategies","volume":"50","author":"Eder","year":"2010","journal-title":"Transfusion"},{"issue":"9896","key":"10.1016\/j.blre.2026.101394_bb0650","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/S0140-6736(12)62197-7","article-title":"Transfusion-related acute lung injury: a clinical review","volume":"382","author":"Vlaar","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0655","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1365-2141.2010.08444.x","article-title":"Guidelines on the use of irradiated blood components","volume":"152","author":"Treleaven","year":"2011","journal-title":"Br J Haematol"},{"issue":"6","key":"10.1016\/j.blre.2026.101394_bb0660","first-page":"1768","article-title":"Posttransfusion purpura: a prospective study on the incidence, pathogenesis, and clinical course","volume":"73","author":"Mueller-Eckhardt","year":"1989","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.blre.2026.101394_bb0665","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1159\/000151350","article-title":"Reactions induced by platelet transfusions","volume":"35","author":"Kiefel","year":"2008","journal-title":"Transfus Med Hemother"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0670","first-page":"107","article-title":"Post-transfusion purpura","volume":"24","author":"Savage","year":"2010","journal-title":"Transfus Med Rev"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0675","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.jtha.2025.09.009","article-title":"Tranexamic acid to prevent bleeding in patients with hematologic malignancies and hypoproliferative thrombocytopenia: a systematic review and meta-analysis of randomized controlled trials with trial sequential analysis","volume":"24","author":"Alsuliman","year":"2026","journal-title":"J Thromb Haemost"},{"issue":"9734","key":"10.1016\/j.blre.2026.101394_bb0680","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0140-6736(10)60835-5","article-title":"Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial","volume":"376","author":"Shakur","year":"2010","journal-title":"Lancet"},{"issue":"10084","key":"10.1016\/j.blre.2026.101394_bb0685","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(17)30638-4","article-title":"Effect of early tranexamic acid administration on mortality, hysterectomy, and other morbidities in women with post-partum haemorrhage (WOMAN): an international, randomised, double-blind, placebo-controlled trial","volume":"389","year":"2017","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0690","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD010562","article-title":"Tranexamic acid for surgical bleeding","volume":"2013","author":"Ker","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.blre.2026.101394_bb0695","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17100","article-title":"The CRASH-2 trial: a randomised controlled trial and economic evaluation of the effects of tranexamic acid on death, vascular occlusive events and transfusion requirement in bleeding trauma patients","volume":"17","author":"Roberts","year":"2013","journal-title":"Health Technol Assess"},{"key":"10.1016\/j.blre.2026.101394_bb0700","article-title":"Tranexamic acid: a narrative review of its current role in hemorrhagic surgery and trauma","volume":"11","author":"Bouras","year":"2024","journal-title":"Front Med (Lausanne)"},{"issue":"10","key":"10.1016\/j.blre.2026.101394_bb0705","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1046\/j.1538-7836.2003.00395.x","article-title":"Thrombosis in inherited factor VII deficiency","volume":"1","author":"Mariani","year":"2003","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0710","first-page":"395","article-title":"The use of recombinant activated factor VII in patients with Glanzmann thrombasthenia","volume":"104","author":"Poon","year":"2004","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.blre.2026.101394_bb0715","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-154-8-201104190-00004","article-title":"Systematic review: benefits and harms of in-hospital use of recombinant factor VIIa for off-label indications","volume":"154","author":"Yank","year":"2011","journal-title":"Ann Intern Med"},{"issue":"19","key":"10.1016\/j.blre.2026.101394_bb0720","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1056\/NEJMoa1006221","article-title":"Safety of recombinant activated factor VII in randomized clinical trials","volume":"363","author":"Levi","year":"2010","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0725","first-page":"149","article-title":"Prothrombin complex concentrates: an update","volume":"8","author":"Franchini","year":"2010","journal-title":"Blood Transfus"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2026.101394_bb0730","first-page":"S7","article-title":"Prothrombin complex concentrates in the treatment of hemorrhage","volume":"128","author":"Riess","year":"2011","journal-title":"Thromb Res"},{"issue":"9","key":"10.1016\/j.blre.2026.101394_bb0735","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1111\/j.1538-7836.2011.04432.x","article-title":"Bleeding risk and reversal strategies for old and new anticoagulants","volume":"9","author":"Levi","year":"2011","journal-title":"J Thromb Haemost"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0740","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1538-7836.2008.02904.x","article-title":"Prothrombin complex concentrate for emergency anticoagulation reversal","volume":"6","author":"Pabinger","year":"2008","journal-title":"J Thromb Haemost"},{"issue":"2","key":"10.1016\/j.blre.2026.101394_bb0745","first-page":"348","article-title":"Management of warfarin-associated bleeding with prothrombin complex concentrate","volume":"107","author":"Majeed","year":"2012","journal-title":"Thromb Haemost"},{"issue":"16","key":"10.1016\/j.blre.2026.101394_bb0750","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1001\/jama.2023.4080","article-title":"Efficacy and safety of early administration of 4-factor prothrombin complex concentrate in patients with Trauma at risk of massive transfusion: the PROCOAG randomized clinical trial","volume":"329","author":"Bouzat","year":"2023","journal-title":"JAMA"},{"issue":"9","key":"10.1016\/j.blre.2026.101394_bb0755","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1182\/blood-2014-08-552000","article-title":"How I use fibrinogen replacement therapy in acquired bleeding","volume":"125","author":"Levy","year":"2015","journal-title":"Blood"},{"issue":"Suppl. 1","key":"10.1016\/j.blre.2026.101394_bb0760","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1365-2516.2000.00059.x","article-title":"Desmopressin (DDAVP) in the treatment of bleeding disorders: the first twenty years","volume":"6","author":"Mannucci","year":"2000","journal-title":"Haemophilia"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0765","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/vox.13573","article-title":"Therapeutic efficacy and safety of pathogen-reduced platelet components versus conventional platelets: a meta-analysis of randomized controlled trials","volume":"119","author":"Cid","year":"2024","journal-title":"Vox Sang"},{"key":"10.1016\/j.blre.2026.101394_bb0770","article-title":"Cold-stored platelets: revisiting assumptions and addressing variability to support implementation","volume":"12","author":"Mahajan","year":"2025","journal-title":"Front Med (Lausanne)"},{"issue":"3","key":"10.1016\/j.blre.2026.101394_bb0775","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103639","article-title":"Cold stored platelets - Increasing understanding and acceptance","volume":"62","author":"Gammon","year":"2023","journal-title":"Transfus Apher Sci"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0780","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1182\/hematology.2022000400","article-title":"Novel platelet products including cold-stored platelets","volume":"2022","author":"Devine","year":"2022","journal-title":"Hematology Am Soc Hematol Educ Program"},{"issue":"4","key":"10.1016\/j.blre.2026.101394_bb0785","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2014.01.011","article-title":"Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells","volume":"14","author":"Nakamura","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"9","key":"10.1016\/j.blre.2026.101394_bb0790","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1111\/jth.13736","article-title":"Platelet production from induced pluripotent stem cells","volume":"15","author":"Sugimoto","year":"2017","journal-title":"J Thromb Haemost"},{"issue":"9","key":"10.1016\/j.blre.2026.101394_bb0795","article-title":"Prophylactic platelet transfusions prior to surgery for people with a low platelet count","volume":"9","author":"Estcourt","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"1","key":"10.1016\/j.blre.2026.101394_bb0800","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1213\/ANE.0000000000004844","article-title":"Essential role of patient blood management in a pandemic: a call for action","volume":"131","author":"Shander","year":"2020","journal-title":"Anesth Analg"}],"container-title":["Blood Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0268960X26000330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:07:07Z","timestamp":1787951227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0268960X26000330"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":160,"alternative-id":["S0268960X26000330"],"URL":"https:\/\/doi.org\/10.1016\/j.blre.2026.101394","relation":{},"ISSN":["0268-960X"],"issn-type":[{"value":"0268-960X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Supportive strategies in thrombocytopenia: Platelet transfusion and beyond","name":"articletitle","label":"Article Title"},{"value":"Blood Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.blre.2026.101394","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101394"}}